Statins are one of the most profitable drug classes. In 2013 alone, statin sales amounted to approximately $29 billion. Pfizer's Lipitor, a prominent statin drug, is noted as the most profitable drug in medical history, with yearly revenue exceeding $12 billion at its peak in 2006. The total sales of statins were projected to reach an estimated $1 trillion by 2020.
A 2015 study in Expert Review of Clinical Pharmacology entitled “Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms” reveals the following:
•Statins, while lowering cholesterol, may paradoxically stimulate atherosclerosis and heart failure.
•Statins are described as mitochondrial toxins, impairing muscle function in the heart and blood vessels by depleting coenzyme Q10, 'heme A', and ATP generation.
•They inhibit vitamin K2 synthesis, which could accelerate artery calcification, and affect selenium-containing proteins, contributing to heart failure.
•The document reviews clinical trials and observational studies suggesting an increase in atherosclerotic disease and heart failure associated with statin use.
Once again a product was rushed to mass adoption, hailed as a miracle drug and after all the money has been made, in this case the most profitable in history, we learn it does exactly the opposite of what it’s supposed to do. To this day doctors dole out Statin scripts like candy.
The pharmaceutical industry is a stain on the world.
Study Referenced:
cardiacos.net/wp-content/upl…